Skip to main content
03 Jul | 2025

The death of a partner and financial stress have been linked to an increased risk of Alzheimer's disease and differences in brain structure

This study suggests that certain stressful life events can impact brain health differently depending on gender and educational level

02 Jul | 2025

Federica Anastasi awarded BrightFocus Foundation grant to advance personalized approaches to Alzheimer’s disease

The project will last two years and aims to uncover why Alzheimer’s disease affects people in different ways and how its course can be more accurately predicted.

19 Jun | 2025

BBRC joins AD-RIDDLE’s second General Assembly in London

This interdisciplinary initiative is designed to provide healthcare providers with a set of innovative tools to improve disease identification and management.

18 Jun | 2025

The BBRC hosts and actively participates in the Euro-PAD 2025 symposium

Almost 100 participants gathered to discuss the latest advancements in neuroimaging and biomarkers for Alzheimer’s disease, as well as to share updates from the Euro-PAD initiative over the past year.

26 May | 2025

New blood biomarker panel accurately detects early Alzheimer’s risk

This fully automated blood test could become a scalable, minimally invasive tool to detect and monitor Alzheimer’s-related changes long before symptoms appear.

15 May | 2025

We receive funding to develop an innovative PET imaging tool for Alzheimer’s neuroinflammation

With a 3-year duration, this project will allow us to explore the role of neuroinflammation in Alzheimer’s disease using the novel [18F]F-DED PET tracer, in collaboration with LMU Munich and Life Molecular Imaging

12 May | 2025

Joan Vives, new Administrative Director of the Foundation and the BBRC

We are strengthening our management structure at a time of sustained growth, with more than 250 employees, 6 research groups and a membership base approaching 100,000

30 Apr | 2025

Increasing physical activity in middle age may protect against alzheimer's disease

The study, published in the journal Alzheimer’s & Dementia, involved 337 people from the ALFA longitudinal cohort of the Barcelonaβeta Brain Research Center (BBRC), with the support of the “la Caixa” Foundation.

29 Apr | 2025

We investigate, we move forward: the 2024 Impact Report is now available

In this document we collect the most notable activity of 2024, a year of key scientific advances and new strategic alliances that consolidate a change in the approach to Alzheimer's disease